Letter: Medical Management With Interventional Therapy Versus Medical Management Alone for Unruptured Brain Arteriovenous Malformations (ARUBA): Final Follow-up of a Multicentre, Nonblinded, Randomised Controlled Trial

Victor Volovici^{1

2}, Joost W Schouten¹, Andreas Gruber³, Torstein R Meling^{4

5}, Ruben Dammers¹

Affiliations

¹ Department of Neurosurgery Erasmus MC Stroke Center Erasmus MC Rotterdam, The Netherlands.
² Center for Medical Decision Making Department of Public Health Erasmus MC Rotterdam, The Netherlands.
³ Department of Neurosurgery Kepler University Hospital Neuromed Campus Linz, Austria.
⁴ Neurosurgery Division Department of Clinical Neurosciences Faculty of Medicine Geneva University Hospitals Geneva, Switzerland.
⁵ Institute of Clinical Medicine Faculty of Medicine University of Oslo Oslo, Norway.

Comment

Victor Volovici et al. Neurosurgery. 2020.

. 2020 Nov 16;87(6):E729-E730.

doi: 10.1093/neuros/nyaa448.

Victor Volovici^{1

2}, Joost W Schouten¹, Andreas Gruber³, Torstein R Meling^{4

5}, Ruben Dammers¹

¹ Department of Neurosurgery Erasmus MC Stroke Center Erasmus MC Rotterdam, The Netherlands.
² Center for Medical Decision Making Department of Public Health Erasmus MC Rotterdam, The Netherlands.
³ Department of Neurosurgery Kepler University Hospital Neuromed Campus Linz, Austria.
⁴ Neurosurgery Division Department of Clinical Neurosciences Faculty of Medicine Geneva University Hospitals Geneva, Switzerland.
⁵ Institute of Clinical Medicine Faculty of Medicine University of Oslo Oslo, Norway.

No abstract available

Comment on

Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial.
Mohr JP, Overbey JR, Hartmann A, Kummer RV, Al-Shahi Salman R, Kim H, van der Worp HB, Parides MK, Stefani MA, Houdart E, Libman R, Pile-Spellman J, Harkness K, Cordonnier C, Moquete E, Biondi A, Klijn CJM, Stapf C, Moskowitz AJ; ARUBA co-investigators. Mohr JP, et al. Lancet Neurol. 2020 Jul;19(7):573-581. doi: 10.1016/S1474-4422(20)30181-2. Lancet Neurol. 2020. PMID: 32562682 Clinical Trial.